Clinical trial No longer in our active list Interventional Ages 65 and up

Improving medication management for elderly nursing home residents

Official title: Impact of a Hospital Medication Expertise on the Rate of Unplanned Hospitalizations at 3 Months of Patients Residing in Nursing Homes (EPAD)

Run by Assistance Publique Hopitaux De Marseille · NCT03640845 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new way to improve medication management for elderly nursing home residents to see if it helps prevent hospital visits by reducing the risks from taking too many medications.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment364 (estimated)
SponsorAssistance Publique Hopitaux De Marseille
Academic / other
Locations1 site (Marseille, Paca)
Trial IDNCT03640845 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are elderly individuals aged 65 and older residing in nursing homes who are at high risk for medication-related issues.

Probably not a fit

Patients with a life expectancy of less than 3 months or those with severe dementia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on optimizing drug prescriptions for elderly patients living in nursing homes, particularly those at high risk of adverse drug reactions. It involves the collaboration of clinical pharmacists with mobile geriatric teams to conduct thorough assessments and provide tele-expertise in medication management. The goal is to reduce unplanned hospitalizations by addressing issues related to polypharmacy and potentially inappropriate drugs. The study is set within a university-based framework, emphasizing a comprehensive approach to geriatric care.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the risk of adverse drug events and unplanned hospitalizations among elderly nursing home residents.

How similar studies have gone: Other studies have shown that interventions involving clinical pharmacists can effectively reduce medication-related problems in elderly populations, suggesting a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age greater than or equal to 65
* Resident in EHPAD
* presenting a high iatrogenic drug risk (Trivalle score between 6-10).
* Ability to provide free, informed and express consent (patient and / or trusted person)
* Affiliated to a social security scheme

Exclusion Criteria:

* Patient with a life expectancy \<3 months
* Patient under 65 years
* Trivale score \<6
* Vulnerable persons within the meaning of French law (adults under guardianship or trusteeship, persons deprived of their liberty)
* Participation in another research protocol in progress
* Patient who has had a medication review (or medication review) known in the last 6 months.
* Patient with severe dementia (MMSE \<18)

Where it's running

  • Assistance Publique Des Hopitaux de Marseille
    Marseille, Paca, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.